Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2161434987', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-ddt02-01', 'title': 'Abstract DDT02-01: In vitro and in vivo characterization of a novel anti-fibroblast growth factor receptor (FGFR) 2 antibody (BAY 1179470) for the treatment of gastric cancer', 'display_name': 'Abstract DDT02-01: In vitro and in vivo characterization of a novel anti-fibroblast growth factor receptor (FGFR) 2 antibody (BAY 1179470) for the treatment of gastric cancer', 'publication_year': 2014, 'publication_date': '2014-10-01', 'ids': {'openalex': 'https://openalex.org/W2161434987', 'doi': 'https://doi.org/10.1158/1538-7445.am2014-ddt02-01', 'mag': '2161434987'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-ddt02-01', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5065895440', 'display_name': 'Charlotte Kopitz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Charlotte Kopitz', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007299835', 'display_name': 'Anette Sommer', 'orcid': 'https://orcid.org/0000-0002-1576-3110'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Anette Sommer', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015618150', 'display_name': 'Stefanie Hammer', 'orcid': 'https://orcid.org/0000-0002-5635-9878'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Stefanie Hammer', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014719891', 'display_name': 'Axel Harrenga', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Axel Harrenga', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040976235', 'display_name': 'Beatrix Stelte‐Ludwig', 'orcid': 'https://orcid.org/0000-0002-1045-1134'}, 'institutions': [{'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}, {'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Beatrix Stelte-Ludwig', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I4210137145', 'https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070239697', 'display_name': 'Frank Dittmer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Frank Dittmer', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067544331', 'display_name': 'Frank Reetz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Frank Reetz', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007686809', 'display_name': 'Ekkehard May', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Ekkehard May', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073224267', 'display_name': 'Ruprecht Zierz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Ruprecht Zierz', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062811024', 'display_name': 'Sabine Wittemer‐Rump', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Sabine Wittemer-Rump', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017327688', 'display_name': 'Christoph A. Schatz', 'orcid': 'https://orcid.org/0000-0001-8028-2631'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Christoph Schatz', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050494348', 'display_name': 'Hung Huynh', 'orcid': 'https://orcid.org/0000-0001-7847-3981'}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'H. T. Huynh', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051451842', 'display_name': 'Karl Ziegelbauer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Karl Ziegelbauer', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5048269157', 'display_name': 'Bertolt Kreft', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210137145', 'display_name': 'National Cancer Centre Singapore', 'ror': 'https://ror.org/03bqk3e80', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210137145']}], 'countries': ['DE', 'SG'], 'is_corresponding': False, 'raw_author_name': 'Bertolt Kreft', 'raw_affiliation_strings': ['Bayer Pharma AG, Berlin, Germany', 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'Bayer Pharma AG, Cologne, Germany', 'Bayer Pharma AG, Wuppertal, Germany'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany; Bayer Pharma AG, Cologne, Germany; Bayer Pharma AG, Wuppertal, Germany; National Cancer Centre Singapore, Division of Cellular & Molecular Research, Singapore.', 'institution_ids': ['https://openalex.org/I67348948', 'https://openalex.org/I4210137145']}, {'raw_affiliation_string': 'Bayer Pharma AG, Berlin, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Cologne, Germany', 'institution_ids': ['https://openalex.org/I67348948']}, {'raw_affiliation_string': 'Bayer Pharma AG, Wuppertal, Germany', 'institution_ids': ['https://openalex.org/I67348948']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.419747, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 73}, 'biblio': {'volume': '74', 'issue': '19_Supplement', 'first_page': 'DDT02', 'last_page': '01'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Signaling Pathway', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Signaling Pathway', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11131', 'display_name': 'Role of Extracellular Matrix in Biological Signaling', 'score': 0.9198, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10746', 'display_name': 'Platelet Disorders and Thrombosis Mechanisms', 'score': 0.9134, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fibroblast-growth-factor', 'display_name': 'Fibroblast Growth Factor', 'score': 0.534946}], 'concepts': [{'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.7270905}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.6845631}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.55386066}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.4831352}, {'id': 'https://openalex.org/C2777292972', 'wikidata': 'https://www.wikidata.org/wiki/Q423762', 'display_name': 'Paclitaxel', 'level': 3, 'score': 0.47502834}, {'id': 'https://openalex.org/C101544691', 'wikidata': 'https://www.wikidata.org/wiki/Q420511', 'display_name': 'Receptor tyrosine kinase', 'level': 3, 'score': 0.46545938}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.4348215}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.41627052}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.379835}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.36722374}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.30514485}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26479775}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2014-ddt02-01', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.87}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2943903912', 'https://openalex.org/W2772062179', 'https://openalex.org/W2342324886', 'https://openalex.org/W2321614358', 'https://openalex.org/W2187345403', 'https://openalex.org/W2094219250', 'https://openalex.org/W2057422871', 'https://openalex.org/W2045698890', 'https://openalex.org/W2029401650', 'https://openalex.org/W2020363833'], 'abstract_inverted_index': {'Abstract': [0], 'Gastric': [1], 'cancer': [2, 54, 116, 177], 'is': [3, 84, 138, 187], 'the': [4, 49, 70, 250, 259, 264], 'second': [5], 'most': [6], 'common': [7], 'cause': [8], 'of': [9, 23, 27, 51, 144, 237, 252, 258, 263], 'cancer-related': [10], 'mortality': [11], 'worldwide,': [12], 'thus': [13], 'new': [14], 'treatment': [15, 50, 251], 'options': [16], 'are': [17], 'urgently': [18], 'needed.': [19], 'In': [20, 231], 'a': [21, 34, 44, 62, 79, 167, 192, 238], 'subset': [22], 'gastric': [24, 53, 115, 176, 253], 'cancers,': [25], 'over-expression': [26], 'fibroblast': [28], 'growth': [29, 106, 241], 'factor': [30, 242], 'receptor': [31, 35, 97, 243], '2': [32, 245], '(FGFR2),': [33], 'tyrosine': [36], 'kinase,': [37], 'has': [38], 'been': [39, 158], 'described': [40], 'and': [41, 100, 113, 150, 179, 233], 'may': [42], 'represent': [43], 'potential': [45], 'therapeutic': [46], 'target': [47], 'for': [48, 249, 267], 'FGFR2-positive': [52], 'patients.': [55], 'To': [56], 'this': [57], 'end,': [58], 'we': [59], 'have': [60, 157], 'generated': [61], 'fully': [63, 139], 'human': [64], 'anti-FGFR2': [65, 169], 'antibody': [66, 170, 246], '(BAY': [67, 247], '1179470)': [68, 248], 'using': [69], 'BioInvent': [71], 'Phage': [72], 'Display': [73], 'library.': [74], 'BAY': [75, 94, 129, 136, 164, 185], '1179470': [76, 95, 130, 137, 165, 186], 'binds': [77], 'to': [78, 92], 'unique': [80], 'FGFR2-specific': [81], 'epitope': [82], 'that': [83], 'present': [85], 'in': [86, 103, 108, 110, 123, 160, 175, 191, 195, 198, 234], 'all': [87], 'FGFR2': [88, 142], 'isoforms.': [89], 'Upon': [90], 'binding': [91], 'FGFR2,': [93], 'induces': [96], 'dimerization,': [98], 'internalization': [99], 'degradation,': [101], 'resulting': [102], 'significant': [104, 154], 'tumor': [105], 'inhibition': [107], 'vivo': [109, 124, 235], 'cell': [111], 'line-based': [112], 'patient-derived': [114], 'models': [117, 178], 'overexpressing': [118], 'FGFR2.': [119], 'Additive': [120], 'anti-tumor': [121, 173], 'efficacy': [122], 'was': [125], 'achieved': [126], 'by': [127], 'combining': [128], 'with': [131, 141, 171], 'either': [132], 'cisplatin': [133], 'or': [134], 'paclitaxel.': [135], 'cross-reactive': [140], 'orthologues': [143], 'mouse,': [145], 'rat,': [146], 'pig,': [147], 'cynomolgus': [148], 'monkey': [149], 'rhesus': [151], 'macaque.': [152], 'No': [153], 'safety': [155, 183], 'findings': [156], 'seen': [159], 'animal': [161], 'studies.': [162], 'Thus,': [163], 'represents': [166], 'novel': [168, 239], 'high': [172], 'activity': [174], 'an': [180], 'excellent': [181], 'preclinical': [182], 'profile.': [184], 'currently': [188], 'being': [189], 'tested': [190], 'first-in-man': [193], 'study': [194], 'all-comers': [196], '(NCT01881217)': [197], 'Japan.': [199], 'Citation': [200], 'Format:': [201], 'Charlotte': [202], 'Kopitz,': [203], 'Anette': [204], 'Sommer,': [205], 'Stefanie': [206], 'Hammer,': [207], 'Axel': [208], 'Harrenga,': [209], 'Beatrix': [210], 'Stelte-Ludwig,': [211], 'Frank': [212, 214], 'Dittmer,': [213], 'Reetz,': [215], 'Ekkehard': [216], 'May,': [217], 'Ruprecht': [218], 'Zierz,': [219], 'Sabine': [220], 'Wittemer-Rump,': [221], 'Christoph': [222], 'Schatz,': [223], 'H.': [224], 'T.': [225], 'Huynh,': [226], 'Karl': [227], 'Ziegelbauer,': [228], 'Bertolt': [229], 'Kreft.': [230], 'vitro': [232], 'characterization': [236], 'anti-fibroblast': [240], '(FGFR)': [244], 'cancer.': [254], '[abstract].': [255], 'In:': [256], 'Proceedings': [257], '105th': [260], 'Annual': [261], 'Meeting': [262], 'American': [265], 'Association': [266], 'Cancer': [268, 279], 'Research;': [269], '2014': [270], 'Apr': [271], '5-9;': [272], 'San': [273], 'Diego,': [274], 'CA.': [275], 'Philadelphia': [276], '(PA):': [277], 'AACR;': [278], 'Res': [280], '2014;74(19': [281], 'Suppl):Abstract': [282], 'nr': [283], 'DDT02-01.': [284], 'doi:10.1158/1538-7445.AM2014-DDT02-01': [285]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2161434987', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-09-26T02:50:18.149831', 'created_date': '2016-06-24'}